CRIT BIT CORNER

Herpes Simplex Virus

HSV Case Study

Core Concepts & Pathophysiology

HSV infection begins when the virus enters the body through vulnerable surfaces. These include moist tissues of the mouth or genitals, or tiny breaks in the skin that are invisible to the eye. Once this barrier is breached, HSV rapidly infects nearby skin or mucosal cells.

Inside these cells, the virus takes over the host’s machinery and moves into the cell nucleus, where it begins aggressive replication. Thousands of new viral particles are produced until the host cell ruptures and dies. This cell destruction explains the classic early features of HSV infection:

• Painful, fragile clusters of fluid-filled blisters (vesicles)
• Local redness, swelling, and tissue breakdown

As infected cells rupture, they release chemical distress signals that trigger an immune response. Blood vessels in the area become leaky, allowing fluid and immune cells to flood the tissue. The combination of cell death, inflammation, and fluid leakage produces the characteristic blistered appearance of an active outbreak. After this initial phase, HSV changes strategy. Rather than continuing to replicate in the skin, the virus retreats into nearby sensory nerves. It enters nerve endings and travels backward along the nerve fiber—a process called retrograde transport—to the sensory nerve ganglion, where nerve cell bodies live. The site of latency depends on where infection began:

• Oral or facial infection → trigeminal ganglion
• Genital infection → sacral dorsal root ganglia

Inside these nerve cells, HSV becomes largely inactive. During this latent phase, the virus produces little to no new virus and causes no symptoms. Importantly, latency does not mean eradication. Certain stressors can disrupt immune control and allow the virus to reactivate:

• Severe illness or critical illness
• Surgery or trauma
• Emotional stress
• Immunosuppressive medications or chemotherapy
• HIV infection
• Significant physiologic stress

When reactivation occurs, the virus resumes replication and travels forward along the nerve—anterograde transport—back to the skin or mucous membranes. This produces recurrent outbreaks, usually in the same location as the original infection. In people with intact immune systems, reactivation is typically localized and self-limited. In patients with impaired immune control, HSV may escape local containment, enter the bloodstream, and disseminate to internal organs, causing esophagitis, pneumonitis, hepatitis, bone marrow suppression, and overwhelming inflammation.

Hydroxocobalamin in Refractory Shock

Why It Works When Pressors Don’t

Hydroxocobalamin is most familiar as an antidote for cyanide poisoning, but in critical care its value extends far beyond toxicology. At its core, hydroxocobalamin is a physiology-modifying drug, not a pathogen-specific therapy. Its role in this case was rooted in shock mechanics, not diagnosis.

Understanding the Problem: Vasoplegia, Not Just Hypotension

In severe inflammatory states—such as disseminated viral infection—the primary issue is often vasoplegia, not volume loss or pump failure. In vasoplegic shock:

• Blood vessels lose their ability to constrict
• Systemic vascular resistance collapses
• Blood pressure becomes poorly responsive to catecholamines
• Tissue perfusion remains inadequate despite escalating pressors

This patient demonstrated classic features of vasoplegia:

• Distributive shock pattern
• Escalating vasopressor requirements
• Severe lactic acidosis
• Poor hemodynamic response despite aggressive resuscitation

To understand why hydroxocobalamin helps, we need to talk about nitric oxide.

Nitric Oxide: Helpful Signal, Dangerous in Excess

Nitric oxide (NO) is a normal signaling molecule that helps regulate vascular tone. In controlled amounts, it allows blood vessels to dilate appropriately. In severe inflammation, nitric oxide production becomes pathologically excessive. Triggers of excessive nitric oxide include:

• Cytokine release (TNF-α, IL-1, IL-6)
• Endothelial injury
• Severe infection (bacterial or viral)
• Ischemia–reperfusion injury

Excess nitric oxide causes:

• Profound vasodilation
• Loss of vascular smooth muscle responsiveness
• Catecholamine resistance
• Impaired mitochondrial oxygen utilization

In other words, oxygen may be present in the blood, but cells cannot effectively use it.

How Hydroxocobalamin Actually Works

Hydroxocobalamin acts as a nitric oxide scavenger. Mechanistically:

• Hydroxocobalamin binds nitric oxide directly
• This reduces free nitric oxide levels in the circulation
• Vascular smooth muscle regains the ability to constrict
• Responsiveness to vasopressors improves

This effect is independent of infection type. It does not matter whether nitric oxide excess is driven by:

• Bacterial sepsis
• Viral inflammation (as in this case)
• Post-cardiac surgery vasoplegia
• Toxin-mediated shock

The common pathway is NO-driven vasodilation.

Why Hydroxocobalamin Was Reasonable in This Case

Early in this patient’s course, the team was faced with:

• Rapidly progressive distributive shock
• Severe metabolic acidosis
• Multi-organ failure
• No clear etiology despite broad evaluation

Cyanide toxicity was considered because:

• Cyanide blocks cellular oxygen use
• The patient showed signs of profound cellular hypoxia
• Shock was refractory and disproportionate to findings

Even after cyanide was excluded, hydroxocobalamin remained physiologically appropriate because:

• The patient had overwhelming inflammation
• Nitric oxide–mediated vasoplegia was likely present
• Conventional pressors alone were insufficient

Hydroxocobalamin did not treat HSV. It treated the hemodynamic consequences of immune-mediated shock.

Clinical Situations Where Hydroxocobalamin May Be Helpful

Hydroxocobalamin has been used (off-label) in:

• Refractory septic shock
• Post–cardiac surgery vasoplegia
• Massive inflammatory states
• Smoke inhalation with suspected cyanide exposure
• Shock states with severe catecholamine resistance

The unifying feature is vasoplegia driven by nitric oxide excess.

What Hydroxocobalamin Is Not

It is important to clarify expectations. Hydroxocobalamin:

• Does not treat infection
• Does not replace antimicrobials or antivirals
• Does not reverse organ damage directly
• Does not fix mitochondrial injury permanently

It is a bridge therapy—a way to stabilize perfusion while definitive treatments (antivirals, source control, organ support) take effect.

Practical Nursing Considerations

From a bedside perspective, nurses may notice:

• Rapid change in urine and skin color (reddish discoloration)
• Interference with some lab assays
• Temporary improvement in blood pressure or pressor responsiveness
• Need for close hemodynamic monitoring after administration

Importantly, response may be partial, not dramatic. Even modest improvement in vascular tone can buy critical time.